-45.28 (-0.71%)
3.15 (+1.15%)| 5-Day | 11,216 |
| 10-Day | 11,200 |
| 30-Day | 7,663 |
| 5-Day | 11,216 |
| 10-Day | 11,200 |
| 30-Day | 7,663 |
4.25 (+1.55%)
| 5-Day | 65,790 |
| 10-Day | 55,925 |
| 30-Day | 33,454 |
| 5-Day | 65,790 |
| 10-Day | 55,925 |
| 30-Day | 33,454 |
COLLAPSE ALL| Days | BSE | NSE |
| 30 | 248.95 | 249.20 |
| 50 | 241.13 | 241.42 |
| 150 | 247.16 | 247.47 |
| 200 | 254.39 | 254.68 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Natco Pharma
| (Sep '11) Quarterly |
(Mar '11) Yearly |
|
| Net Sales | 112.93 | 371.74 |
| Other Income | 1.56 | 0.72 |
| PBDIT | 31.59 | 92.52 |
| Net Profit | 16.03 | 52.12 |
| Total Share Capital | 28.15 |
| Net Worth | 346.91 |
| Total Debt | 219.88 |
| Net Block | 254.15 |
| Investments | 71.19 |
| Net Current Assets | 142.74 |
| Total Assets | 566.79 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 541.30 | -0.12 | 565.75 | 404.00 | 56,056.05 |
| Cipla | 349.00 | -0.78 | 359.00 | 273.60 | 28,021.96 |
| Dr Reddys Labs | 1619.85 | -1.19 | 1716.00 | 1387.00 | 27,463.59 |
| Lupin | 458.80 | -2.90 | 492.00 | 363.00 | 20,491.02 |
| Ranbaxy Labs | 443.30 | -1.83 | 570.00 | 366.50 | 18,708.66 |
| More » | |||||
| Sep' 11 | Jun' 11 | Mar' 11 | Dec' 10 | |
| Promoter | 63.11 | 62.88 | 62.84 | 62.69 |
| FII | 6.36 | 6.50 | 6.84 | 6.85 |
| DII | 8.86 | 8.12 | 6.87 | 6.74 |
| Others | 21.67 | 22.50 | 23.45 | 23.72 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| ICICI Prudential Discovery Fund (G) | 1,069,767 |
| ICICI Prudential MidCap Fund (G) | 654,646 |
| ICICI Prudential MIP 25 (G) | 188,150 |
| ICICI Prudential Child Care Plan - Gift Plan | 164,776 |
|
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Aurobindo Pharma | Naveen Patnaik | Vodafone Essar | Suzlon Energy | Tamil Nadu | Bonus share | State Bank of India | Sheila Dikshit | DLF